カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒト白癬薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Human Tinea Pedis Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19400）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19400
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヒト白癬薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ヒト白癬薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒト白癬薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒト白癬薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・クリーム、スプレー、その他

用途別セグメントは次のように区分されます。
・オフラインストア、オンラインストア

世界のヒト白癬薬市場の主要な市場プレーヤーは以下のとおりです。
・Bayer、GSK、Johnson & Johnson、Novartis、Bausch Health、TEVA、Taro Pharmaceutical、WellSpring Pharma、Crown Laboratories、Medimetriks Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒト白癬薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト白癬薬メーカーの企業概要、2019年～2022年までのヒト白癬薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト白癬薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒト白癬薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒト白癬薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒト白癬薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒト白癬薬の産業チェーンを掲載しています。
・第13、14、15章では、ヒト白癬薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ヒト白癬薬の概要
- 種類別分析（2017年vs2021年vs2028年）：クリーム、スプレー、その他
- 用途別分析（2017年vs2021年vs2028年）：オフラインストア、オンラインストア
- 世界のヒト白癬薬市場規模・予測
- 世界のヒト白癬薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bayer、GSK、Johnson & Johnson、Novartis、Bausch Health、TEVA、Taro Pharmaceutical、WellSpring Pharma、Crown Laboratories、Medimetriks Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：クリーム、スプレー、その他
・用途別分析2017年-2028年：オフラインストア、オンラインストア
・ヒト白癬薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒト白癬薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒト白癬薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒト白癬薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒト白癬薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Tinea Pedis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Tinea Pedis Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Offline Store accounting for % of the Human Tinea Pedis Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cream segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Tinea Pedis Drugs include Bayer, GSK, Johnson & Johnson, Novartis, and Bausch Health, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Tinea Pedis Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cream
Spray
Others
Market segment by Application can be divided into
Offline Store
Online Store
The key market players for global Human Tinea Pedis Drugs market are listed below:
Bayer
GSK
Johnson & Johnson
Novartis
Bausch Health
TEVA
Taro Pharmaceutical
WellSpring Pharma
Crown Laboratories
Medimetriks Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Tinea Pedis Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Tinea Pedis Drugs, with price, sales, revenue and global market share of Human Tinea Pedis Drugs from 2019 to 2022.
Chapter 3, the Human Tinea Pedis Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Tinea Pedis Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Tinea Pedis Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Tinea Pedis Drugs.
Chapter 13, 14, and 15, to describe Human Tinea Pedis Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Human Tinea Pedis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Tinea Pedis Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cream
1.2.3 Spray
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Tinea Pedis Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Offline Store
1.3.3 Online Store
1.4 Global Human Tinea Pedis Drugs Market Size & Forecast
1.4.1 Global Human Tinea Pedis Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Tinea Pedis Drugs Sales in Volume (2017-2028)
1.4.3 Global Human Tinea Pedis Drugs Price (2017-2028)
1.5 Global Human Tinea Pedis Drugs Production Capacity Analysis
1.5.1 Global Human Tinea Pedis Drugs Total Production Capacity (2017-2028)
1.5.2 Global Human Tinea Pedis Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Tinea Pedis Drugs Market Drivers
1.6.2 Human Tinea Pedis Drugs Market Restraints
1.6.3 Human Tinea Pedis Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Human Tinea Pedis Drugs Product and Services
2.1.4 Bayer Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Human Tinea Pedis Drugs Product and Services
2.2.4 GSK Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Human Tinea Pedis Drugs Product and Services
2.3.4 Johnson & Johnson Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Human Tinea Pedis Drugs Product and Services
2.4.4 Novartis Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business
2.5.3 Bausch Health Human Tinea Pedis Drugs Product and Services
2.5.4 Bausch Health Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 TEVA
2.6.1 TEVA Details
2.6.2 TEVA Major Business
2.6.3 TEVA Human Tinea Pedis Drugs Product and Services
2.6.4 TEVA Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Taro Pharmaceutical
2.7.1 Taro Pharmaceutical Details
2.7.2 Taro Pharmaceutical Major Business
2.7.3 Taro Pharmaceutical Human Tinea Pedis Drugs Product and Services
2.7.4 Taro Pharmaceutical Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 WellSpring Pharma
2.8.1 WellSpring Pharma Details
2.8.2 WellSpring Pharma Major Business
2.8.3 WellSpring Pharma Human Tinea Pedis Drugs Product and Services
2.8.4 WellSpring Pharma Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Crown Laboratories
2.9.1 Crown Laboratories Details
2.9.2 Crown Laboratories Major Business
2.9.3 Crown Laboratories Human Tinea Pedis Drugs Product and Services
2.9.4 Crown Laboratories Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Medimetriks Pharmaceuticals
2.10.1 Medimetriks Pharmaceuticals Details
2.10.2 Medimetriks Pharmaceuticals Major Business
2.10.3 Medimetriks Pharmaceuticals Human Tinea Pedis Drugs Product and Services
2.10.4 Medimetriks Pharmaceuticals Human Tinea Pedis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Tinea Pedis Drugs Breakdown Data by Manufacturer
3.1 Global Human Tinea Pedis Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Tinea Pedis Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Tinea Pedis Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Human Tinea Pedis Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Human Tinea Pedis Drugs Manufacturer Market Share in 2021
3.5 Global Human Tinea Pedis Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Tinea Pedis Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Tinea Pedis Drugs Market Size by Region
4.1.1 Global Human Tinea Pedis Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Human Tinea Pedis Drugs Revenue by Region (2017-2028)
4.2 North America Human Tinea Pedis Drugs Revenue (2017-2028)
4.3 Europe Human Tinea Pedis Drugs Revenue (2017-2028)
4.4 Asia-Pacific Human Tinea Pedis Drugs Revenue (2017-2028)
4.5 South America Human Tinea Pedis Drugs Revenue (2017-2028)
4.6 Middle East and Africa Human Tinea Pedis Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Tinea Pedis Drugs Sales in Volume by Type (2017-2028)
5.2 Global Human Tinea Pedis Drugs Revenue by Type (2017-2028)
5.3 Global Human Tinea Pedis Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Tinea Pedis Drugs Sales in Volume by Application (2017-2028)
6.2 Global Human Tinea Pedis Drugs Revenue by Application (2017-2028)
6.3 Global Human Tinea Pedis Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Tinea Pedis Drugs Sales by Type (2017-2028)
7.2 North America Human Tinea Pedis Drugs Sales by Application (2017-2028)
7.3 North America Human Tinea Pedis Drugs Market Size by Country
7.3.1 North America Human Tinea Pedis Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Human Tinea Pedis Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Tinea Pedis Drugs Sales by Type (2017-2028)
8.2 Europe Human Tinea Pedis Drugs Sales by Application (2017-2028)
8.3 Europe Human Tinea Pedis Drugs Market Size by Country
8.3.1 Europe Human Tinea Pedis Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Tinea Pedis Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Tinea Pedis Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Human Tinea Pedis Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Human Tinea Pedis Drugs Market Size by Region
9.3.1 Asia-Pacific Human Tinea Pedis Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Tinea Pedis Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Tinea Pedis Drugs Sales by Type (2017-2028)
10.2 South America Human Tinea Pedis Drugs Sales by Application (2017-2028)
10.3 South America Human Tinea Pedis Drugs Market Size by Country
10.3.1 South America Human Tinea Pedis Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Human Tinea Pedis Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Tinea Pedis Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Human Tinea Pedis Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Human Tinea Pedis Drugs Market Size by Country
11.3.1 Middle East & Africa Human Tinea Pedis Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Tinea Pedis Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Tinea Pedis Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Tinea Pedis Drugs
12.3 Human Tinea Pedis Drugs Production Process
12.4 Human Tinea Pedis Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Tinea Pedis Drugs Typical Distributors
13.3 Human Tinea Pedis Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Human Tinea Pedis Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Tinea Pedis Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Human Tinea Pedis Drugs Product and Services
Table 6. Bayer Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Human Tinea Pedis Drugs Product and Services
Table 10. GSK Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Human Tinea Pedis Drugs Product and Services
Table 14. Johnson & Johnson Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Human Tinea Pedis Drugs Product and Services
Table 18. Novartis Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 20. Bausch Health Major Business
Table 21. Bausch Health Human Tinea Pedis Drugs Product and Services
Table 22. Bausch Health Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. TEVA Basic Information, Manufacturing Base and Competitors
Table 24. TEVA Major Business
Table 25. TEVA Human Tinea Pedis Drugs Product and Services
Table 26. TEVA Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Taro Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Taro Pharmaceutical Major Business
Table 29. Taro Pharmaceutical Human Tinea Pedis Drugs Product and Services
Table 30. Taro Pharmaceutical Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. WellSpring Pharma Basic Information, Manufacturing Base and Competitors
Table 32. WellSpring Pharma Major Business
Table 33. WellSpring Pharma Human Tinea Pedis Drugs Product and Services
Table 34. WellSpring Pharma Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Crown Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Crown Laboratories Major Business
Table 37. Crown Laboratories Human Tinea Pedis Drugs Product and Services
Table 38. Crown Laboratories Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Medimetriks Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Medimetriks Pharmaceuticals Major Business
Table 41. Medimetriks Pharmaceuticals Human Tinea Pedis Drugs Product and Services
Table 42. Medimetriks Pharmaceuticals Human Tinea Pedis Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Human Tinea Pedis Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Human Tinea Pedis Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Human Tinea Pedis Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Human Tinea Pedis Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Human Tinea Pedis Drugs Production Site of Key Manufacturer
Table 48. Human Tinea Pedis Drugs New Entrant and Capacity Expansion Plans
Table 49. Human Tinea Pedis Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Human Tinea Pedis Drugs Sales by Region (2017-2022) & (K Units)
Table 51. Global Human Tinea Pedis Drugs Sales by Region (2023-2028) & (K Units)
Table 52. Global Human Tinea Pedis Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Human Tinea Pedis Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Human Tinea Pedis Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Global Human Tinea Pedis Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Global Human Tinea Pedis Drugs Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Human Tinea Pedis Drugs Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Human Tinea Pedis Drugs Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Human Tinea Pedis Drugs Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Human Tinea Pedis Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Global Human Tinea Pedis Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Global Human Tinea Pedis Drugs Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Human Tinea Pedis Drugs Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Human Tinea Pedis Drugs Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Human Tinea Pedis Drugs Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Human Tinea Pedis Drugs Sales by Country (2017-2022) & (K Units)
Table 67. North America Human Tinea Pedis Drugs Sales by Country (2023-2028) & (K Units)
Table 68. North America Human Tinea Pedis Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Human Tinea Pedis Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Human Tinea Pedis Drugs Sales by Type (2017-2022) & (K Units)
Table 71. North America Human Tinea Pedis Drugs Sales by Type (2023-2028) & (K Units)
Table 72. North America Human Tinea Pedis Drugs Sales by Application (2017-2022) & (K Units)
Table 73. North America Human Tinea Pedis Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Europe Human Tinea Pedis Drugs Sales by Country (2017-2022) & (K Units)
Table 75. Europe Human Tinea Pedis Drugs Sales by Country (2023-2028) & (K Units)
Table 76. Europe Human Tinea Pedis Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Human Tinea Pedis Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Human Tinea Pedis Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Europe Human Tinea Pedis Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Europe Human Tinea Pedis Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Europe Human Tinea Pedis Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Human Tinea Pedis Drugs Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Human Tinea Pedis Drugs Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Human Tinea Pedis Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Human Tinea Pedis Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Human Tinea Pedis Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Human Tinea Pedis Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Human Tinea Pedis Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Human Tinea Pedis Drugs Sales by Application (2023-2028) & (K Units)
Table 90. South America Human Tinea Pedis Drugs Sales by Country (2017-2022) & (K Units)
Table 91. South America Human Tinea Pedis Drugs Sales by Country (2023-2028) & (K Units)
Table 92. South America Human Tinea Pedis Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Human Tinea Pedis Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Human Tinea Pedis Drugs Sales by Type (2017-2022) & (K Units)
Table 95. South America Human Tinea Pedis Drugs Sales by Type (2023-2028) & (K Units)
Table 96. South America Human Tinea Pedis Drugs Sales by Application (2017-2022) & (K Units)
Table 97. South America Human Tinea Pedis Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Human Tinea Pedis Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Human Tinea Pedis Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Human Tinea Pedis Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Human Tinea Pedis Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Human Tinea Pedis Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Human Tinea Pedis Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Human Tinea Pedis Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Human Tinea Pedis Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Human Tinea Pedis Drugs Raw Material
Table 107. Key Manufacturers of Human Tinea Pedis Drugs Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Human Tinea Pedis Drugs Typical Distributors
Table 111. Human Tinea Pedis Drugs Typical Customers
List of Figures
Figure 1. Human Tinea Pedis Drugs Picture
Figure 2. Global Human Tinea Pedis Drugs Revenue Market Share by Type in 2021
Figure 3. Cream
Figure 4. Spray
Figure 5. Others
Figure 6. Global Human Tinea Pedis Drugs Revenue Market Share by Application in 2021
Figure 7. Offline Store
Figure 8. Online Store
Figure 9. Global Human Tinea Pedis Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Human Tinea Pedis Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Human Tinea Pedis Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Human Tinea Pedis Drugs Price (2017-2028) & (US$/Unit)
Figure 13. Global Human Tinea Pedis Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Human Tinea Pedis Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Human Tinea Pedis Drugs Market Drivers
Figure 16. Human Tinea Pedis Drugs Market Restraints
Figure 17. Human Tinea Pedis Drugs Market Trends
Figure 18. Global Human Tinea Pedis Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Human Tinea Pedis Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Human Tinea Pedis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Human Tinea Pedis Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Human Tinea Pedis Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Human Tinea Pedis Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Human Tinea Pedis Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Human Tinea Pedis Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Human Tinea Pedis Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Human Tinea Pedis Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Human Tinea Pedis Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Human Tinea Pedis Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Human Tinea Pedis Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Human Tinea Pedis Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Human Tinea Pedis Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Human Tinea Pedis Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Human Tinea Pedis Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Human Tinea Pedis Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Human Tinea Pedis Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Human Tinea Pedis Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Human Tinea Pedis Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Human Tinea Pedis Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Human Tinea Pedis Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Human Tinea Pedis Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Human Tinea Pedis Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Human Tinea Pedis Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Human Tinea Pedis Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Human Tinea Pedis Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Human Tinea Pedis Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Human Tinea Pedis Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Human Tinea Pedis Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Human Tinea Pedis Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Human Tinea Pedis Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Human Tinea Pedis Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Human Tinea Pedis Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Human Tinea Pedis Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Human Tinea Pedis Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Human Tinea Pedis Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Human Tinea Pedis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Human Tinea Pedis Drugs in 2021
Figure 77. Manufacturing Process Analysis of Human Tinea Pedis Drugs
Figure 78. Human Tinea Pedis Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 体部白癬治療の世界市場2023年：局所、経口
  • 世界のヒトヘルパーウイルス5（HHV-5）治療薬市場2022年：市場規模予測（～2028年）
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19400 )"世界のヒト白癬薬市場2022年：市場規模予測（～2028年）" (英文：Global Human Tinea Pedis Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。